TY - JOUR T1 - Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding JF - Evidence Based Medicine JO - Evid Based Med SP - 99 LP - 99 DO - 10.1136/ebmed-2015-110167 VL - 20 IS - 3 AU - Gérard Helft Y1 - 2015/06/01 UR - http://ebm.bmj.com/content/20/3/99.abstract N2 - Commentary on: Mauri L, Kereiakes DJ, Yeh RW, et al, ; DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014;371:2155–66OpenUrlCrossRefPubMedWeb of Science.The implantation of drug-eluting stents (DES) has become a standard treatment for the management of patients with coronary artery disease. The use of dual antiplatelet therapy (DAPT) is critically important for the prevention of coronary stent thrombosis. Current clinical guidelines recommend at least 6–12 months of treatment after DES implantation; however, a longer duration of DAPT may be beneficial.1This study is an international, randomised, placebo-controlled trial that was designed to determine the benefits and risks of continuing … ER -